Abstract Details Title A Combined Analysis of Data from Four Randomized, Double-Blind, Placebo-Controlled Trials of Parenteral Cladribine and One Open-Label Pilot Study To Assess the Safety and Tolerability Profile of Repeated Periods of Cladribine Treatment in Patients with Progressive or Relapsing Multiple Sclerosis Topic MS and Related Diseases Presentation(s) (-) Poster/Presentation Number 180 Objective Background Design/Methods Results Conclusions Authors/Disclosures Stuart D. Cook, MD, FAAN (Rutgers) No disclosure on file Tali R. Sorets Tali R. Sorets has nothing to disclose.